290 related articles for article (PubMed ID: 21622249)
1. Podocyte dysfunction in aging--related glomerulosclerosis.
Camici M; Carpi A; Cini G; Galetta F; Abraham N
Front Biosci (Schol Ed); 2011 Jun; 3(3):995-1006. PubMed ID: 21622249
[TBL] [Abstract][Full Text] [Related]
2. ACE-inhibition increases podocyte number in experimental glomerular disease independent of proliferation.
Zhang J; Yanez D; Floege A; Lichtnekert J; Krofft RD; Liu ZH; Pippin JW; Shankland SJ
J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):234-48. PubMed ID: 25143333
[TBL] [Abstract][Full Text] [Related]
3. Renin induces apoptosis in podocytes through a receptor-mediated, angiotensin II-independent mechanism.
Yuan H; Ren ZL; Hu FQ; Liang W; Ding GH
Am J Med Sci; 2012 Dec; 344(6):441-6. PubMed ID: 22874619
[TBL] [Abstract][Full Text] [Related]
4. Role of Podocyte Injury in Glomerulosclerosis.
Lu CC; Wang GH; Lu J; Chen PP; Zhang Y; Hu ZB; Ma KL
Adv Exp Med Biol; 2019; 1165():195-232. PubMed ID: 31399967
[TBL] [Abstract][Full Text] [Related]
5. The podocyte's response to injury: role in proteinuria and glomerulosclerosis.
Shankland SJ
Kidney Int; 2006 Jun; 69(12):2131-47. PubMed ID: 16688120
[TBL] [Abstract][Full Text] [Related]
6. Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition.
Ortmann J; Amann K; Brandes RP; Kretzler M; Münter K; Parekh N; Traupe T; Lange M; Lattmann T; Barton M
Hypertension; 2004 Dec; 44(6):974-81. PubMed ID: 15545511
[TBL] [Abstract][Full Text] [Related]
7. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.
Daehn I; Casalena G; Zhang T; Shi S; Fenninger F; Barasch N; Yu L; D'Agati V; Schlondorff D; Kriz W; Haraldsson B; Bottinger EP
J Clin Invest; 2014 Apr; 124(4):1608-21. PubMed ID: 24590287
[TBL] [Abstract][Full Text] [Related]
8. Podocyte injury and its consequences.
Nagata M
Kidney Int; 2016 Jun; 89(6):1221-30. PubMed ID: 27165817
[TBL] [Abstract][Full Text] [Related]
9. Glomerular Aging and Focal Global Glomerulosclerosis: A Podometric Perspective.
Hodgin JB; Bitzer M; Wickman L; Afshinnia F; Wang SQ; O'Connor C; Yang Y; Meadowbrooke C; Chowdhury M; Kikuchi M; Wiggins JE; Wiggins RC
J Am Soc Nephrol; 2015 Dec; 26(12):3162-78. PubMed ID: 26038526
[TBL] [Abstract][Full Text] [Related]
10. Renin-Angiotensin-Aldosterone System Inhibition Increases Podocyte Derivation from Cells of Renin Lineage.
Lichtnekert J; Kaverina NV; Eng DG; Gross KW; Kutz JN; Pippin JW; Shankland SJ
J Am Soc Nephrol; 2016 Dec; 27(12):3611-3627. PubMed ID: 27080979
[TBL] [Abstract][Full Text] [Related]
11. Testosterone and 17β-estradiol have opposite effects on podocyte apoptosis that precedes glomerulosclerosis in female estrogen receptor knockout mice.
Doublier S; Lupia E; Catanuto P; Periera-Simon S; Xia X; Korach K; Berho M; Elliot SJ; Karl M
Kidney Int; 2011 Feb; 79(4):404-13. PubMed ID: 20962747
[TBL] [Abstract][Full Text] [Related]
12. Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction.
Wiggins JE; Goyal M; Sanden SK; Wharram BL; Shedden KA; Misek DE; Kuick RD; Wiggins RC
J Am Soc Nephrol; 2005 Oct; 16(10):2953-66. PubMed ID: 16120818
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic role of TGF-β in the progression of podocyte diseases.
Lee HS
Histol Histopathol; 2011 Jan; 26(1):107-16. PubMed ID: 21117032
[TBL] [Abstract][Full Text] [Related]
14. Glomerular scarring: can we delay or even reverse glomerulosclerosis by RAAS inhibition?
Moeller MJ
Nephrol Dial Transplant; 2010 Jul; 25(7):2101-3. PubMed ID: 20388634
[No Abstract] [Full Text] [Related]
15. Effects of TGF-beta on podocyte growth and disease progression in proliferative podocytopathies.
Lee HS; Song CY
Kidney Blood Press Res; 2010; 33(1):24-9. PubMed ID: 20185928
[TBL] [Abstract][Full Text] [Related]
16. Podocyte repopulation contributes to regression of glomerular injury induced by ACE inhibition.
Macconi D; Sangalli F; Bonomelli M; Conti S; Condorelli L; Gagliardini E; Remuzzi G; Remuzzi A
Am J Pathol; 2009 Mar; 174(3):797-807. PubMed ID: 19164508
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of disease reversal in focal and segmental glomerulosclerosis.
Yang HC; Fogo AB
Adv Chronic Kidney Dis; 2014 Sep; 21(5):442-7. PubMed ID: 25168834
[TBL] [Abstract][Full Text] [Related]
18. [The role of podocyte damage in the pathogenesis of glomerulosclerosis and possible repair mechanisms].
Ronconi E; Mazzinghi B; Sagrinati C; Angelotti ML; Ballerini L; Parente E; Romagnani P; Lazzeri E; Lasagni L
G Ital Nefrol; 2009; 26(6):660-9. PubMed ID: 19918748
[TBL] [Abstract][Full Text] [Related]
19. Postnatal podocyte gain: Is the jury still out?
Puelles VG; Moeller MJ
Semin Cell Dev Biol; 2019 Jul; 91():147-152. PubMed ID: 31178004
[TBL] [Abstract][Full Text] [Related]
20. Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat.
Kim YH; Goyal M; Kurnit D; Wharram B; Wiggins J; Holzman L; Kershaw D; Wiggins R
Kidney Int; 2001 Sep; 60(3):957-68. PubMed ID: 11532090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
